Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05293522 · ClinicalTrials.gov registry record · Phase 2
A Study of NTX-001 in the Treatment and Prevention of Facial Paralysis Requiring Surgical Repair.
A Phase 2 study, sponsored by Neuraptive Therapeutics.
- Terminated
- Registry status
- Phase 2
- Development phase
- 2
- Enrollment target
NCT05293522 is a Phase 2 study that was terminated before completion, run by Neuraptive Therapeutics. The registered enrollment target is 2 participants.
The verdict
NCT05293522, a Phase 2 study, was terminated before completion, sponsored by Neuraptive Therapeutics.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 2 participants
- Enrollment target
Study Summary
This study involves the use of an Investigational Product called NTX-001. It is a product used in the repair of nerve injuries. It is used in the operating room. The main purposes of this study are to 1) see how safe NTX-001 is when used in nerve repair and, 2) see if your nerve becomes functional in a shorter period of time when compared to what is normally done to treat nerve injuries.
Interventions
- COMBINATION_PRODUCT NTX-001
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2022-07-12 |
| Est. Completion | 2023-08-22 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05293522
The ClinicalTrials.gov registry entry for NCT05293522 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Neuraptive Therapeutics, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which NTX-001 is the first listed.
NCT05293522 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05293522 about?
NCT05293522 is a clinical study titled "A Study of NTX-001 in the Treatment and Prevention of Facial Paralysis Requiring Surgical Repair.". This study involves the use of an Investigational Product called NTX-001. It is a product used in the repair of nerve injuries. It is used in the operating room. The main purposes of this study are to 1) see how safe NTX-001 is when used in nerve repair and, 2) see if your nerve becomes functional i...
What is the current status of trial NCT05293522?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 2 participants. The study started on 2022-07-12. Estimated completion is 2023-08-22.
What interventions are being tested in trial NCT05293522?
The interventions under investigation include: NTX-001 (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT05293522?
This trial is sponsored by Neuraptive Therapeutics, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.